Skip to main content
Caplight Logo









Culture Biosciences

Culture Biosciences

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.culturebiosciences.com/

Last Round

Series C

Dec 16, 2025

Est. Valuation

$1.71M

Total Funding Raised

$100.62M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Culture Biosciences is a biotechnology company that develops automated bioreactors and cloud-native software to optimize manufacturing processes for sensitive cell cultures and high cell density fermentation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Smart Manufacturing, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

bioreactorbioprocessingcell culturecloud-integrated bioreactorbiotech lab automationprocess developmentbioreactor-as-a-servicedigital twindesign of experimentsDOEbiopharma R&Dlab-on-a-cloudAI-driven bioprocessingremote lab monitoringcell therapy manufacturingsmart manufacturingbiotech SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Culture Biosciences Comparables

Compare Culture Biosciences with similar companies based on industry and business-model similarity.

Culture Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mytos
79%
QB Systems
78%
Donaldson Company
77%

Culture Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CDec 16, 2025
Series BOct 14, 2021
Series AMar 4, 2020
SeedFeb 12, 2019
AcceleratorJan 1, 2018

Culture Biosciences Investors

Notable investors and investment history

Culture Biosciences investors
InvestorRounds
S32Series A, Series B, Series C, Seed
Refactor CapitalSeed
The Production BoardSeries A, Series B
Synthesis CapitalSeries B, Series C
Cultivian Sandbox VenturesSeries B, Series C, Series A
Craft VenturesSeries B
Northpond VenturesSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 36% MoM.

  • Apr 14, 2026

    Mike Stapleton appointed to the Board of Directors.

Culture Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Culture Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Culture Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range67
Year Founded2016
Last FundingDec 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?